# ABRIDGE - PE Due Diligence Dashboard (RAG)

*Generated: 2025-11-14T23:52:57.517509*

## Company Overview
**Legal Name:** Abridge, Inc.  
**Brand Name:** Abridge  
**Website:** [abridge.com](https://www.abridge.com/)  
**Headquarters:** Pittsburgh, PA, USA  
**Founded Year:** 2019  
**Categories:** Generative AI, Healthcare Technology, Clinical Documentation, AI for Healthcare, Natural Language Processing  

## Business Model and GTM
Abridge offers a Generative AI Platform for Clinical Conversations, providing clinically useful and billable AI notes at the point of care, integrated directly into EHR workflows. The company also features the Abridge Contextual Reasoning Engine, which powers trusted billable, clinically useful, and compliant notes at the point of care. Additionally, the Abridge AI Platform is used for Clinical Documentation by major healthcare systems like Johns Hopkins and Mayo Clinic.

## Funding & Investor Profile
Total amount raised: Not disclosed.  
Last disclosed valuation: Not disclosed.  
Last round name: Not disclosed.  
Last round date: Not disclosed.  

## Growth Momentum
Recent events include:
- **Funding announcement for Real Time Prior Authorization** on August 12, 2025.
- **Partnership with AltaMed Health Services Corporation** on April 29, 2025.
- **Sharp HealthCare Chooses Abridge for Clinical Documentation** on April 10, 2025.

## Visibility & Market Sentiment
The company states it is a pioneer in Generative AI for Healthcare. It has been featured in various press releases and blogs, indicating a positive market sentiment towards its innovations and insights in AI for healthcare.

## Risks and Challenges
Not disclosed.

## Outlook
Not disclosed.

## Disclosure Gaps
- Total amount raised
- Last disclosed valuation
- Last round name
- Last round date
- Specific risks and challenges
- Outlook for the company